About Slingshot AI
Slingshot AI is building what it calls a foundation model for psychology, addressing the global mental health crisis through artificial intelligence. The company's flagship product, Ash, is the first AI specifically designed for therapy rather than as a general assistant. Unlike traditional AI chatbots that provide answers, Ash is designed to increase users' sense of autonomy, competence, and relatedness by questioning like a therapist and holding users accountable. The platform learns from multiple therapeutic approaches including CBT, DBT, ACT, gestalt, and psychodynamic therapy, recognizing that different approaches work for different people. Slingshot AI was founded in January 2024 by Daniel Cahn and Neil Parikh (co-founder of Casper). After 18 months of development with over 50,000 beta users including therapists, Ash launched publicly in July 2025 as a free iOS and Android app. The company's mission is to make mental healthcare more accessible and help people change their lives in the ways they want, leveraging Large Language Models to provide deeply personalized support that respects individual value systems and cultural norms.
Mission & Story
Mission
To make mental healthcare more accessible and help people change their lives in the ways they want
Founding Story
Founded in January 2024 by Daniel Cahn and Neil Parikh (co-founder of Casper mattress company). Neil Parikh brought his experience building consumer brands to mental health, recognizing during the pandemic that many people couldn't access mental health professionals. The founding team includes Dr. Derrick Hull as Clinical Lead, who previously led Clinical R&D at Talkspace.
Clinical Focus
Medical conditions and clinical areas addressed by Slingshot AI.
Who It Serves
Milestones & Awards
Recent Milestones
Public launch of Ash app in July 2025 after 18 months of development. Extended Series A funding announced July 2025, bringing total raised to $93M. Beta program reached 50,000 users.
Awards & Recognition
Featured by Lori Gottlieb (therapist and author). Covered by Forbes, Associated Press, Endpoints News, Behavioral Health Business.
Company Details
- Founded
- 2024
- Headquarters
- New York City, NY, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 48 →
AbleTo
AI-powered mental health and digital therapeutics platform delivering behavioral health interventions and therapy support.
Akili
Akili Interactive creates FDA-authorized digital therapeutics delivered through video game experiences to treat cognitive impairments. Their flagship products include EndeavorRx, the first FDA-approved prescription video game for children with ADHD, and EndeavorOTC for adults with ADHD.
Alma
Alma is a mental health care platform that connects clients with therapists who accept insurance across all 50 states. The company supports both clients seeking affordable therapy and mental health providers with practice management tools and insurance credentialing.
Alto Neuroscience
Alto Neuroscience develops biology-driven precision medicines for neuropsychiatric conditions. The company uses brain biology measurements to predict clinical response and identify patients most likely to benefit from their drug candidates.
BeMe Health
BeMe is a mobile mental health platform designed specifically for teens and young adults. The app provides a safe space for mood tracking, personalized content, live 1:1 coaching, and crisis support to improve emotional well-being and mental health.
Big Health
Big Health provides FDA-cleared digital therapeutics delivering cognitive behavioral therapy (CBT) for insomnia and anxiety. Their prescription products, SleepioRx and DaylightRx, serve health systems, health plans, and employers with evidence-based mental health solutions backed by 100+ peer-reviewed publications.
Blueprint Health
Blueprint provides an AI-powered assistant for mental health therapists that automates clinical documentation, generates treatment plans, and delivers clinical support. The platform works alongside existing EHRs or as a standalone AI-native EHR with integrated scheduling, telehealth, billing, and insurance management.
Boulder Care
Boulder Care provides telehealth-based addiction treatment for substance use disorder (SUD), including opioid use disorder (OUD) and alcohol use disorder (AUD). The company delivers whole-person, coordinated outpatient care through a secure mobile app, including medication-assisted treatment (MAT) with Suboxone and other medications, supported by dedicated care teams.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.